SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '6YV'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1GHM_A_CEDA1_1 (BETA-LACTAMASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	6 / 12	SER A 70 LYS A 73 SER A 130 ASN A 132 LYS A 234 GLY A 236	6YV A 301 (-1.7A) 6YV A 301 ( 3.8A) 6YV A 301 (-2.6A) 6YV A 301 (-3.7A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A)	0.44A	1ghmA-5ll7A: 37.7	1ghmA-5ll7A: 13.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1I2W_A_CFXA1300_1 (BETA-LACTAMASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	8 / 12	SER A 70 LYS A 73 SER A 130 ASN A 132 GLU A 166 THR A 216 LYS A 234 GLY A 236	6YV A 301 (-1.7A) 6YV A 301 ( 3.8A) 6YV A 301 (-2.6A) 6YV A 301 (-3.7A) 6YV A 301 (-2.7A) 6YV A 301 ( 4.2A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A)	0.48A	1i2wA-5ll7A: 41.5	1i2wA-5ll7A: 18.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1I2W_B_CFXB2300_1 (BETA-LACTAMASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	7 / 12	SER A 70 LYS A 73 SER A 130 ASN A 132 GLU A 166 GLY A 236 ARG A 220	6YV A 301 (-1.7A) 6YV A 301 ( 3.8A) 6YV A 301 (-2.6A) 6YV A 301 (-3.7A) 6YV A 301 (-2.7A) 6YV A 301 ( 4.0A) 6YV A 301 ( 3.7A)	1.07A	1i2wB-5ll7A: 41.8	1i2wB-5ll7A: 18.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1I2W_B_CFXB2300_1 (BETA-LACTAMASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	7 / 12	SER A 70 LYS A 73 SER A 130 ASN A 132 GLU A 166 THR A 216 GLY A 236	6YV A 301 (-1.7A) 6YV A 301 ( 3.8A) 6YV A 301 (-2.6A) 6YV A 301 (-3.7A) 6YV A 301 (-2.7A) 6YV A 301 ( 4.2A) 6YV A 301 ( 4.0A)	0.44A	1i2wB-5ll7A: 41.8	1i2wB-5ll7A: 18.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1YMX_A_CFXA1001_1 (BETA-LACTAMASE CTX-M-9)	5ll7	BETA-LACTAMASE (Escherichia coli)	9 / 12	SER A 70 LYS A 73 SER A 130 ASN A 132 GLU A 166 ASN A 170 THR A 216 LYS A 234 GLY A 236	6YV A 301 (-1.7A) 6YV A 301 ( 3.8A) 6YV A 301 (-2.6A) 6YV A 301 (-3.7A) 6YV A 301 (-2.7A) 6YV A 301 (-2.9A) 6YV A 301 ( 4.2A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A)	0.71A	1ymxA-5ll7A: 42.9	1ymxA-5ll7A: 17.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1YMX_B_CFXB1002_1 (BETA-LACTAMASE CTX-M-9)	5ll7	BETA-LACTAMASE (Escherichia coli)	8 / 12	SER A 70 LYS A 73 SER A 130 ASN A 132 GLU A 166 ASN A 170 LYS A 234 GLY A 236	6YV A 301 (-1.7A) 6YV A 301 ( 3.8A) 6YV A 301 (-2.6A) 6YV A 301 (-3.7A) 6YV A 301 (-2.7A) 6YV A 301 (-2.9A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A)	0.68A	1ymxB-5ll7A: 43.1	1ymxB-5ll7A: 17.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3HLW_A_CE3A301_1 (CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	7 / 12	LYS A 73 SER A 130 ASN A 132 ASN A 170 THR A 216 LYS A 234 GLY A 236	6YV A 301 ( 3.8A) 6YV A 301 (-2.6A) 6YV A 301 (-3.7A) 6YV A 301 (-2.9A) 6YV A 301 ( 4.2A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A)	0.72A	3hlwA-5ll7A: 43.0	3hlwA-5ll7A: 16.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3HLW_B_CE3B302_1 (CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	7 / 12	SER A 130 ASN A 132 ASN A 170 THR A 216 LYS A 234 THR A 235 GLY A 236	6YV A 301 (-2.6A) 6YV A 301 (-3.7A) 6YV A 301 (-2.9A) 6YV A 301 ( 4.2A) 6YV A 301 (-3.6A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A)	0.66A	3hlwB-5ll7A: 43.0	3hlwB-5ll7A: 16.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3HUO_A_PNNA300_0 (CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	6 / 12	LYS A 73 ASN A 132 ASN A 170 LYS A 234 THR A 235 GLY A 236	6YV A 301 ( 3.8A) 6YV A 301 (-3.7A) 6YV A 301 (-2.9A) 6YV A 301 (-3.6A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A)	0.58A	3huoA-5ll7A: 42.8	3huoA-5ll7A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3HUO_B_PNNB301_0 (CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	5 / 12	LYS A 73 ASN A 132 ASN A 170 LYS A 234 GLY A 236	6YV A 301 ( 3.8A) 6YV A 301 (-3.7A) 6YV A 301 (-2.9A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A)	0.58A	3huoB-5ll7A: 42.9	3huoB-5ll7A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MZE_A_CFXA364_1 (D-ALANYL-D-ALANINE CARBOXYPEPTIDASE DACA)	5ll7	BETA-LACTAMASE (Escherichia coli)	6 / 12	SER A 70 ASN A 132 LEU A 167 THR A 235 GLY A 236 ARG A 220	6YV A 301 (-1.7A) 6YV A 301 (-3.7A) None 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A) 6YV A 301 ( 3.7A)	0.87A	3mzeA-5ll7A: 21.3	3mzeA-5ll7A: 11.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MZE_A_CFXA364_1 (D-ALANYL-D-ALANINE CARBOXYPEPTIDASE DACA)	5ll7	BETA-LACTAMASE (Escherichia coli)	6 / 12	SER A 70 LYS A 73 ASN A 132 THR A 235 GLY A 236 ARG A 220	6YV A 301 (-1.7A) 6YV A 301 ( 3.8A) 6YV A 301 (-3.7A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A) 6YV A 301 ( 3.7A)	0.73A	3mzeA-5ll7A: 21.3	3mzeA-5ll7A: 11.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NY4_A_SMXA308_1 (BETA-LACTAMASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	9 / 12	SER A 70 SER A 130 ASN A 170 THR A 216 ARG A 220 LYS A 234 THR A 235 GLY A 236 THR A 237	6YV A 301 (-1.7A) 6YV A 301 (-2.6A) 6YV A 301 (-2.9A) 6YV A 301 ( 4.2A) 6YV A 301 ( 3.7A) 6YV A 301 (-3.6A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A) 6YV A 301 (-3.6A)	0.30A	3ny4A-5ll7A: 39.9	3ny4A-5ll7A: 19.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3Q07_A_WPPA300_1 (BETA-LACTAMASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	6 / 12	LYS A 73 SER A 130 ASN A 132 ASN A 170 LYS A 234 GLY A 236	6YV A 301 ( 3.8A) 6YV A 301 (-2.6A) 6YV A 301 (-3.7A) 6YV A 301 (-2.9A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A)	0.62A	3q07A-5ll7A: 42.8	3q07A-5ll7A: 16.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3Q07_B_WPPB400_1 (BETA-LACTAMASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	6 / 12	LYS A 73 SER A 130 ASN A 132 ASN A 170 LYS A 234 GLY A 236	6YV A 301 ( 3.8A) 6YV A 301 (-2.6A) 6YV A 301 (-3.7A) 6YV A 301 (-2.9A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A)	0.60A	3q07B-5ll7A: 43.0	3q07B-5ll7A: 16.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3SH8_A_CEDA1_1 (BETA-LACTAMASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	6 / 12	SER A 70 SER A 130 ASN A 132 LYS A 234 THR A 235 GLY A 236	6YV A 301 (-1.7A) 6YV A 301 (-2.6A) 6YV A 301 (-3.7A) 6YV A 301 (-3.6A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A)	0.49A	3sh8A-5ll7A: 40.6	3sh8A-5ll7A: 17.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3SH8_B_CEDB1_1 (BETA-LACTAMASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	6 / 12	SER A 70 LYS A 73 SER A 130 ASN A 132 LYS A 234 GLY A 236	6YV A 301 (-1.7A) 6YV A 301 ( 3.8A) 6YV A 301 (-2.6A) 6YV A 301 (-3.7A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A)	0.58A	3sh8B-5ll7A: 40.2	3sh8B-5ll7A: 17.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EUZ_A_MEMA401_1 (CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1)	5ll7	BETA-LACTAMASE (Escherichia coli)	10 / 12	LYS A 73 SER A 130 ASN A 132 LEU A 167 ASN A 170 THR A 216 LYS A 234 THR A 235 GLY A 236 THR A 237	6YV A 301 ( 3.8A) 6YV A 301 (-2.6A) 6YV A 301 (-3.7A) None 6YV A 301 (-2.9A) 6YV A 301 ( 4.2A) 6YV A 301 (-3.6A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A) 6YV A 301 (-3.6A)	0.45A	4euzA-5ll7A: 45.4	4euzA-5ll7A: 22.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FH2_A_0RNA303_1 (BETA-LACTAMASE SHV-1)	5ll7	BETA-LACTAMASE (Escherichia coli)	5 / 10	SER A 130 ASN A 132 LYS A 234 THR A 235 GLY A 236	6YV A 301 (-2.6A) 6YV A 301 (-3.7A) 6YV A 301 (-3.6A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A)	0.41A	4fh2A-5ll7A: 35.2	4fh2A-5ll7A: 16.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4N9K_A_CEDA301_1 (BETA-LACTAMASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	7 / 12	SER A 70 SER A 130 ASN A 132 ASN A 170 LYS A 234 THR A 235 GLY A 236	6YV A 301 (-1.7A) 6YV A 301 (-2.6A) 6YV A 301 (-3.7A) 6YV A 301 (-2.9A) 6YV A 301 (-3.6A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A)	0.50A	4n9kA-5ll7A: 42.0	4n9kA-5ll7A: 17.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4N9K_B_CEDB301_1 (BETA-LACTAMASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	7 / 12	SER A 70 SER A 130 ASN A 132 ASN A 170 LYS A 234 THR A 235 GLY A 236	6YV A 301 (-1.7A) 6YV A 301 (-2.6A) 6YV A 301 (-3.7A) 6YV A 301 (-2.9A) 6YV A 301 (-3.6A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A)	0.48A	4n9kB-5ll7A: 42.0	4n9kB-5ll7A: 17.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4PB1_A_RBVA501_1 (NUPC FAMILY PROTEIN)	5ll7	BETA-LACTAMASE (Escherichia coli)	5 / 12	GLY A 74 ALA A 77 LEU A 148 ASN A 136 ASN A 132	None None None None 6YV A 301 (-3.7A)	1.37A	4pb1A-5ll7A: undetectable	4pb1A-5ll7A: 13.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4PM5_A_CE3A301_1 (BETA-LACTAMASE CTX-M-14)	5ll7	BETA-LACTAMASE (Escherichia coli)	7 / 12	SER A 130 ASN A 132 ASN A 170 THR A 216 LYS A 234 THR A 235 GLY A 236	6YV A 301 (-2.6A) 6YV A 301 (-3.7A) 6YV A 301 (-2.9A) 6YV A 301 ( 4.2A) 6YV A 301 (-3.6A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A)	0.65A	4pm5A-5ll7A: 43.1	4pm5A-5ll7A: 16.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4PM5_A_CE3A301_1 (BETA-LACTAMASE CTX-M-14)	5ll7	BETA-LACTAMASE (Escherichia coli)	6 / 12	SER A 130 THR A 216 LYS A 234 THR A 235 GLY A 236 GLY A 239	6YV A 301 (-2.6A) 6YV A 301 ( 4.2A) 6YV A 301 (-3.6A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A) None	0.88A	4pm5A-5ll7A: 43.1	4pm5A-5ll7A: 16.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4PM7_A_CE3A301_1 (BETA-LACTAMASE CTX-M-14)	5ll7	BETA-LACTAMASE (Escherichia coli)	7 / 12	LYS A 73 SER A 130 ASN A 132 ASN A 170 THR A 216 LYS A 234 GLY A 236	6YV A 301 ( 3.8A) 6YV A 301 (-2.6A) 6YV A 301 (-3.7A) 6YV A 301 (-2.9A) 6YV A 301 ( 4.2A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A)	0.71A	4pm7A-5ll7A: 43.0	4pm7A-5ll7A: 16.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4PM9_A_CE3A301_1 (BETA-LACTAMASE CTX-M-14)	5ll7	BETA-LACTAMASE (Escherichia coli)	7 / 12	SER A 130 ASN A 132 ASN A 170 THR A 216 LYS A 234 THR A 235 GLY A 236	6YV A 301 (-2.6A) 6YV A 301 (-3.7A) 6YV A 301 (-2.9A) 6YV A 301 ( 4.2A) 6YV A 301 (-3.6A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A)	0.63A	4pm9A-5ll7A: 42.6	4pm9A-5ll7A: 16.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4ZXI_A_GLYA1402_0 (TYROCIDINE SYNTHETASE 3)	5ll7	BETA-LACTAMASE (Escherichia coli)	4 / 7	ASP A 246 ILE A 221 GLY A 232 THR A 235	None None None 6YV A 301 (-3.6A)	1.16A	4zxiA-5ll7A: undetectable	4zxiA-5ll7A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5GHY_A_CEDA301_1 (BETA-LACTAMASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	6 / 12	SER A 70 SER A 130 ASN A 132 ASN A 170 LYS A 234 GLY A 236	6YV A 301 (-1.7A) 6YV A 301 (-2.6A) 6YV A 301 (-3.7A) 6YV A 301 (-2.9A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A)	0.55A	5ghyA-5ll7A: 42.2	5ghyA-5ll7A: 17.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5GHY_B_CEDB301_1 (BETA-LACTAMASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	6 / 12	SER A 70 SER A 130 ASN A 132 ASN A 170 LYS A 234 GLY A 236	6YV A 301 (-1.7A) 6YV A 301 (-2.6A) 6YV A 301 (-3.7A) 6YV A 301 (-2.9A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A)	0.52A	5ghyB-5ll7A: 42.2	5ghyB-5ll7A: 17.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5GHZ_A_CEDA301_1 (BETA-LACTAMASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	7 / 11	SER A 70 SER A 130 ASN A 132 ASN A 170 LYS A 234 THR A 235 GLY A 236	6YV A 301 (-1.7A) 6YV A 301 (-2.6A) 6YV A 301 (-3.7A) 6YV A 301 (-2.9A) 6YV A 301 (-3.6A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A)	0.50A	5ghzA-5ll7A: 42.1	5ghzA-5ll7A: 17.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5GHZ_B_CEDB301_1 (BETA-LACTAMASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	7 / 10	SER A 70 SER A 130 ASN A 132 ASN A 170 LYS A 234 THR A 235 GLY A 236	6YV A 301 (-1.7A) 6YV A 301 (-2.6A) 6YV A 301 (-3.7A) 6YV A 301 (-2.9A) 6YV A 301 (-3.6A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A)	0.50A	5ghzB-5ll7A: 42.1	5ghzB-5ll7A: 17.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5OJ0_A_9WTA801_0 (PENICILLIN-BINDING PROTEIN 2X)	5ll7	BETA-LACTAMASE (Escherichia coli)	5 / 12	SER A 130 ASN A 132 THR A 216 GLY A 236 THR A 237	6YV A 301 (-2.6A) 6YV A 301 (-3.7A) 6YV A 301 ( 4.2A) 6YV A 301 ( 4.0A) 6YV A 301 (-3.6A)	1.23A	5oj0A-5ll7A: 7.3	5oj0A-5ll7A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YVN_A_ACTA305_0 (GLUTATHIONE S-TRANSFERASE OMEGA-1)	5ll7	BETA-LACTAMASE (Escherichia coli)	4 / 6	LEU A 169 LYS A 73 LEU A 76 LEU A 139	None 6YV A 301 ( 3.8A) None None	0.98A	5yvnA-5ll7A: undetectable	5yvnA-5ll7A: undetectable
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6B5Y_B_9F2B400_1 (BETA-LACTAMASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	9 / 12	SER A 70 SER A 130 ASN A 170 THR A 216 ARG A 220 LYS A 234 THR A 235 GLY A 236 THR A 237	6YV A 301 (-1.7A) 6YV A 301 (-2.6A) 6YV A 301 (-2.9A) 6YV A 301 ( 4.2A) 6YV A 301 ( 3.7A) 6YV A 301 (-3.6A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A) 6YV A 301 (-3.6A)	0.43A	6b5yB-5ll7A: 40.2	6b5yB-5ll7A: 40.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6B5Y_B_9F2B400_1 (BETA-LACTAMASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	6 / 12	THR A 216 ARG A 220 LYS A 234 THR A 235 THR A 237 GLY A 239	6YV A 301 ( 4.2A) 6YV A 301 ( 3.7A) 6YV A 301 (-3.6A) 6YV A 301 (-3.6A) 6YV A 301 (-3.6A) None	0.82A	6b5yB-5ll7A: 40.2	6b5yB-5ll7A: 40.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6B5Y_D_9F2D400_1 (BETA-LACTAMASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	9 / 12	SER A 70 SER A 130 ASN A 170 THR A 216 LYS A 234 THR A 235 GLY A 236 THR A 237 GLU A 276	6YV A 301 (-1.7A) 6YV A 301 (-2.6A) 6YV A 301 (-2.9A) 6YV A 301 ( 4.2A) 6YV A 301 (-3.6A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A) 6YV A 301 (-3.6A) None	0.47A	6b5yD-5ll7A: 40.3	6b5yD-5ll7A: 40.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6B68_B_9F2B301_1 (BETA-LACTAMASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	8 / 12	SER A 70 SER A 130 ASN A 170 THR A 216 LYS A 234 THR A 235 GLY A 236 THR A 237	6YV A 301 (-1.7A) 6YV A 301 (-2.6A) 6YV A 301 (-2.9A) 6YV A 301 ( 4.2A) 6YV A 301 (-3.6A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A) 6YV A 301 (-3.6A)	0.36A	6b68B-5ll7A: 40.3	6b68B-5ll7A: 40.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6B68_D_9F2D400_1 (BETA-LACTAMASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	9 / 12	SER A 70 SER A 130 ASN A 170 THR A 216 ARG A 220 LYS A 234 GLY A 236 THR A 237 GLU A 276	6YV A 301 (-1.7A) 6YV A 301 (-2.6A) 6YV A 301 (-2.9A) 6YV A 301 ( 4.2A) 6YV A 301 ( 3.7A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A) 6YV A 301 (-3.6A) None	0.38A	6b68D-5ll7A: 40.2	6b68D-5ll7A: 40.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6B69_B_9F2B301_1 (BETA-LACTAMASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	8 / 12	SER A 70 SER A 130 ASN A 170 THR A 216 LYS A 234 THR A 235 GLY A 236 THR A 237	6YV A 301 (-1.7A) 6YV A 301 (-2.6A) 6YV A 301 (-2.9A) 6YV A 301 ( 4.2A) 6YV A 301 (-3.6A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A) 6YV A 301 (-3.6A)	0.40A	6b69A-5ll7A: 40.2 6b69B-5ll7A: 40.2	6b69A-5ll7A: 40.00 6b69B-5ll7A: 40.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6B69_D_9F2D301_1 (BETA-LACTAMASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	10 / 12	SER A 70 SER A 130 ASN A 170 THR A 216 ARG A 220 LYS A 234 THR A 235 GLY A 236 THR A 237 GLU A 276	6YV A 301 (-1.7A) 6YV A 301 (-2.6A) 6YV A 301 (-2.9A) 6YV A 301 ( 4.2A) 6YV A 301 ( 3.7A) 6YV A 301 (-3.6A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A) 6YV A 301 (-3.6A) None	0.38A	6b69D-5ll7A: 40.1	6b69D-5ll7A: 40.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6B69_D_9F2D301_1 (BETA-LACTAMASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	6 / 12	THR A 216 ARG A 220 THR A 235 THR A 237 GLY A 239 GLU A 276	6YV A 301 ( 4.2A) 6YV A 301 ( 3.7A) 6YV A 301 (-3.6A) 6YV A 301 (-3.6A) None None	0.78A	6b69D-5ll7A: 40.1	6b69D-5ll7A: 40.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6B6A_B_9F2B301_1 (BETA-LACTAMASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	9 / 12	SER A 70 SER A 130 ASN A 170 THR A 216 ARG A 220 LYS A 234 THR A 235 GLY A 236 THR A 237	6YV A 301 (-1.7A) 6YV A 301 (-2.6A) 6YV A 301 (-2.9A) 6YV A 301 ( 4.2A) 6YV A 301 ( 3.7A) 6YV A 301 (-3.6A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A) 6YV A 301 (-3.6A)	0.36A	6b6aB-5ll7A: 40.3	6b6aB-5ll7A: 40.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6B6A_D_9F2D301_1 (BETA-LACTAMASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	9 / 12	SER A 70 SER A 130 ASN A 170 ARG A 220 LYS A 234 THR A 235 GLY A 236 THR A 237 GLU A 276	6YV A 301 (-1.7A) 6YV A 301 (-2.6A) 6YV A 301 (-2.9A) 6YV A 301 ( 3.7A) 6YV A 301 (-3.6A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A) 6YV A 301 (-3.6A) None	0.38A	6b6aD-5ll7A: 40.3	6b6aD-5ll7A: 40.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6B6C_A_9F2A301_1 (BETA-LACTAMASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	8 / 12	SER A 70 SER A 130 ASN A 170 ARG A 220 LYS A 234 THR A 235 GLY A 236 THR A 237	6YV A 301 (-1.7A) 6YV A 301 (-2.6A) 6YV A 301 (-2.9A) 6YV A 301 ( 3.7A) 6YV A 301 (-3.6A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A) 6YV A 301 (-3.6A)	0.47A	6b6cA-5ll7A: 40.0	6b6cA-5ll7A: 40.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6B6C_A_9F2A301_1 (BETA-LACTAMASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	6 / 12	SER A 130 PRO A 104 ARG A 220 LYS A 234 THR A 235 THR A 237	6YV A 301 (-2.6A) None 6YV A 301 ( 3.7A) 6YV A 301 (-3.6A) 6YV A 301 (-3.6A) 6YV A 301 (-3.6A)	1.34A	6b6cA-5ll7A: 40.0	6b6cA-5ll7A: 40.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6B6D_A_9F2A302_1 (BETA-LACTAMASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	8 / 12	SER A 70 SER A 130 ASN A 170 THR A 216 LYS A 234 THR A 235 GLY A 236 THR A 237	6YV A 301 (-1.7A) 6YV A 301 (-2.6A) 6YV A 301 (-2.9A) 6YV A 301 ( 4.2A) 6YV A 301 (-3.6A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A) 6YV A 301 (-3.6A)	0.40A	6b6dA-5ll7A: 40.0	6b6dA-5ll7A: 40.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6B6D_A_9F2A302_1 (BETA-LACTAMASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	6 / 12	SER A 130 THR A 216 LYS A 234 THR A 235 THR A 237 GLY A 239	6YV A 301 (-2.6A) 6YV A 301 ( 4.2A) 6YV A 301 (-3.6A) 6YV A 301 (-3.6A) 6YV A 301 (-3.6A) None	0.87A	6b6dA-5ll7A: 40.0	6b6dA-5ll7A: 40.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6B6E_A_9F2A302_1 (BETA-LACTAMASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	9 / 12	SER A 70 SER A 130 ASN A 170 THR A 216 ARG A 220 LYS A 234 THR A 235 GLY A 236 THR A 237	6YV A 301 (-1.7A) 6YV A 301 (-2.6A) 6YV A 301 (-2.9A) 6YV A 301 ( 4.2A) 6YV A 301 ( 3.7A) 6YV A 301 (-3.6A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A) 6YV A 301 (-3.6A)	0.37A	6b6eA-5ll7A: 40.1	6b6eA-5ll7A: 40.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6B6F_A_9F2A301_1 (BETA-LACTAMASE)	5ll7	BETA-LACTAMASE (Escherichia coli)	8 / 12	CSS A 69 SER A 70 SER A 130 ASN A 170 LYS A 234 THR A 235 GLY A 236 THR A 237	None 6YV A 301 (-1.7A) 6YV A 301 (-2.6A) 6YV A 301 (-2.9A) 6YV A 301 (-3.6A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A) 6YV A 301 (-3.6A)	0.61A	6b6fA-5ll7A: 39.6	6b6fA-5ll7A: 40.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6C79_A_CE3A301_1 (BETA-LACTAMASE TOHO-1)	5ll7	BETA-LACTAMASE (Escherichia coli)	6 / 12	SER A 130 ASN A 132 ASN A 170 THR A 216 LYS A 234 GLY A 236	6YV A 301 (-2.6A) 6YV A 301 (-3.7A) 6YV A 301 (-2.9A) 6YV A 301 ( 4.2A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A)	0.66A	6c79A-5ll7A: 43.3	6c79A-5ll7A: 33.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6C79_A_CE3A301_1 (BETA-LACTAMASE TOHO-1)	5ll7	BETA-LACTAMASE (Escherichia coli)	5 / 12	SER A 130 THR A 216 LYS A 234 GLY A 236 GLY A 239	6YV A 301 (-2.6A) 6YV A 301 ( 4.2A) 6YV A 301 (-3.6A) 6YV A 301 ( 4.0A) None	0.92A	6c79A-5ll7A: 43.3	6c79A-5ll7A: 33.75

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1GHM_A_CEDA1_1","BETA-LACTAMASE","5ll7","BETA-LACTAMASE","Escherichia coli",6,"SER A  70;LYS A  73;SER A 130;ASN A 132;LYS A 234;GLY A 236","6YV A 301 (-1.7A);6YV A 301 ( 3.8A);6YV A 301 (-2.6A);6YV A 301 (-3.7A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A)","0.44A","1ghmA-5ll7A:37.7",null],["1I2W_A_CFXA1300_1","BETA-LACTAMASE","5ll7","BETA-LACTAMASE","Escherichia coli",8,"SER A  70;LYS A  73;SER A 130;ASN A 132;GLU A 166;THR A 216;LYS A 234;GLY A 236","6YV A 301 (-1.7A);6YV A 301 ( 3.8A);6YV A 301 (-2.6A);6YV A 301 (-3.7A);6YV A 301 (-2.7A);6YV A 301 ( 4.2A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A)","0.48A","1i2wA-5ll7A:41.5","1ghmA-5ll7A:13.89"],["1I2W_B_CFXB2300_1","BETA-LACTAMASE","5ll7","BETA-LACTAMASE","Escherichia coli",7,"SER A  70;LYS A  73;SER A 130;ASN A 132;GLU A 166;GLY A 236;ARG A 220","6YV A 301 (-1.7A);6YV A 301 ( 3.8A);6YV A 301 (-2.6A);6YV A 301 (-3.7A);6YV A 301 (-2.7A);6YV A 301 ( 4.0A);6YV A 301 ( 3.7A)","1.07A","1i2wB-5ll7A:41.8","1i2wA-5ll7A:18.62"],["1I2W_B_CFXB2300_1","BETA-LACTAMASE","5ll7","BETA-LACTAMASE","Escherichia coli",7,"SER A  70;LYS A  73;SER A 130;ASN A 132;GLU A 166;THR A 216;GLY A 236","6YV A 301 (-1.7A);6YV A 301 ( 3.8A);6YV A 301 (-2.6A);6YV A 301 (-3.7A);6YV A 301 (-2.7A);6YV A 301 ( 4.2A);6YV A 301 ( 4.0A)","0.44A","1i2wB-5ll7A:41.8","1i2wB-5ll7A:18.62"],["1YMX_A_CFXA1001_1","BETA-LACTAMASE CTX-M-9","5ll7","BETA-LACTAMASE","Escherichia coli",9,"SER A  70;LYS A  73;SER A 130;ASN A 132;GLU A 166;ASN A 170;THR A 216;LYS A 234;GLY A 236","6YV A 301 (-1.7A);6YV A 301 ( 3.8A);6YV A 301 (-2.6A);6YV A 301 (-3.7A);6YV A 301 (-2.7A);6YV A 301 (-2.9A);6YV A 301 ( 4.2A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A)","0.71A","1ymxA-5ll7A:42.9","1i2wB-5ll7A:18.62"],["1YMX_B_CFXB1002_1","BETA-LACTAMASE CTX-M-9","5ll7","BETA-LACTAMASE","Escherichia coli",8,"SER A  70;LYS A  73;SER A 130;ASN A 132;GLU A 166;ASN A 170;LYS A 234;GLY A 236","6YV A 301 (-1.7A);6YV A 301 ( 3.8A);6YV A 301 (-2.6A);6YV A 301 (-3.7A);6YV A 301 (-2.7A);6YV A 301 (-2.9A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A)","0.68A","1ymxB-5ll7A:43.1","1ymxA-5ll7A:17.00"],["3HLW_A_CE3A301_1","CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE","5ll7","BETA-LACTAMASE","Escherichia coli",7,"LYS A  73;SER A 130;ASN A 132;ASN A 170;THR A 216;LYS A 234;GLY A 236","6YV A 301 ( 3.8A);6YV A 301 (-2.6A);6YV A 301 (-3.7A);6YV A 301 (-2.9A);6YV A 301 ( 4.2A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A)","0.72A","3hlwA-5ll7A:43.0","1ymxB-5ll7A:17.00"],["3HLW_B_CE3B302_1","CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE","5ll7","BETA-LACTAMASE","Escherichia coli",7,"SER A 130;ASN A 132;ASN A 170;THR A 216;LYS A 234;THR A 235;GLY A 236","6YV A 301 (-2.6A);6YV A 301 (-3.7A);6YV A 301 (-2.9A);6YV A 301 ( 4.2A);6YV A 301 (-3.6A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A)","0.66A","3hlwB-5ll7A:43.0","3hlwA-5ll7A:16.60"],["3HUO_A_PNNA300_0","CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE","5ll7","BETA-LACTAMASE","Escherichia coli",6,"LYS A  73;ASN A 132;ASN A 170;LYS A 234;THR A 235;GLY A 236","6YV A 301 ( 3.8A);6YV A 301 (-3.7A);6YV A 301 (-2.9A);6YV A 301 (-3.6A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A)","0.58A","3huoA-5ll7A:42.8","3hlwB-5ll7A:16.60"],["3HUO_B_PNNB301_0","CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE","5ll7","BETA-LACTAMASE","Escherichia coli",5,"LYS A  73;ASN A 132;ASN A 170;LYS A 234;GLY A 236","6YV A 301 ( 3.8A);6YV A 301 (-3.7A);6YV A 301 (-2.9A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A)","0.58A","3huoB-5ll7A:42.9","3huoA-5ll7A:undetectable"],["3MZE_A_CFXA364_1","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE DACA","5ll7","BETA-LACTAMASE","Escherichia coli",6,"SER A  70;ASN A 132;LEU A 167;THR A 235;GLY A 236;ARG A 220","6YV A 301 (-1.7A);6YV A 301 (-3.7A);None;6YV A 301 (-3.6A);6YV A 301 ( 4.0A);6YV A 301 ( 3.7A)","0.87A","3mzeA-5ll7A:21.3","3huoB-5ll7A:undetectable"],["3MZE_A_CFXA364_1","D-ALANYL-D-ALANINE CARBOXYPEPTIDASE DACA","5ll7","BETA-LACTAMASE","Escherichia coli",6,"SER A  70;LYS A  73;ASN A 132;THR A 235;GLY A 236;ARG A 220","6YV A 301 (-1.7A);6YV A 301 ( 3.8A);6YV A 301 (-3.7A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A);6YV A 301 ( 3.7A)","0.73A","3mzeA-5ll7A:21.3","3mzeA-5ll7A:11.85"],["3NY4_A_SMXA308_1","BETA-LACTAMASE","5ll7","BETA-LACTAMASE","Escherichia coli",9,"SER A  70;SER A 130;ASN A 170;THR A 216;ARG A 220;LYS A 234;THR A 235;GLY A 236;THR A 237","6YV A 301 (-1.7A);6YV A 301 (-2.6A);6YV A 301 (-2.9A);6YV A 301 ( 4.2A);6YV A 301 ( 3.7A);6YV A 301 (-3.6A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A);6YV A 301 (-3.6A)","0.30A","3ny4A-5ll7A:39.9","3mzeA-5ll7A:11.85"],["3Q07_A_WPPA300_1","BETA-LACTAMASE","5ll7","BETA-LACTAMASE","Escherichia coli",6,"LYS A  73;SER A 130;ASN A 132;ASN A 170;LYS A 234;GLY A 236","6YV A 301 ( 3.8A);6YV A 301 (-2.6A);6YV A 301 (-3.7A);6YV A 301 (-2.9A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A)","0.62A","3q07A-5ll7A:42.8","3ny4A-5ll7A:19.38"],["3Q07_B_WPPB400_1","BETA-LACTAMASE","5ll7","BETA-LACTAMASE","Escherichia coli",6,"LYS A  73;SER A 130;ASN A 132;ASN A 170;LYS A 234;GLY A 236","6YV A 301 ( 3.8A);6YV A 301 (-2.6A);6YV A 301 (-3.7A);6YV A 301 (-2.9A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A)","0.60A","3q07B-5ll7A:43.0","3q07A-5ll7A:16.60"],["3SH8_A_CEDA1_1","BETA-LACTAMASE","5ll7","BETA-LACTAMASE","Escherichia coli",6,"SER A  70;SER A 130;ASN A 132;LYS A 234;THR A 235;GLY A 236","6YV A 301 (-1.7A);6YV A 301 (-2.6A);6YV A 301 (-3.7A);6YV A 301 (-3.6A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A)","0.49A","3sh8A-5ll7A:40.6","3q07B-5ll7A:16.60"],["3SH8_B_CEDB1_1","BETA-LACTAMASE","5ll7","BETA-LACTAMASE","Escherichia coli",6,"SER A  70;LYS A  73;SER A 130;ASN A 132;LYS A 234;GLY A 236","6YV A 301 (-1.7A);6YV A 301 ( 3.8A);6YV A 301 (-2.6A);6YV A 301 (-3.7A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A)","0.58A","3sh8B-5ll7A:40.2","3sh8A-5ll7A:17.30"],["4EUZ_A_MEMA401_1","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","5ll7","BETA-LACTAMASE","Escherichia coli",10,"LYS A  73;SER A 130;ASN A 132;LEU A 167;ASN A 170;THR A 216;LYS A 234;THR A 235;GLY A 236;THR A 237","6YV A 301 ( 3.8A);6YV A 301 (-2.6A);6YV A 301 (-3.7A);None;6YV A 301 (-2.9A);6YV A 301 ( 4.2A);6YV A 301 (-3.6A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A);6YV A 301 (-3.6A)","0.45A","4euzA-5ll7A:45.4","3sh8B-5ll7A:17.30"],["4FH2_A_0RNA303_1","BETA-LACTAMASE SHV-1","5ll7","BETA-LACTAMASE","Escherichia coli",5,"SER A 130;ASN A 132;LYS A 234;THR A 235;GLY A 236","6YV A 301 (-2.6A);6YV A 301 (-3.7A);6YV A 301 (-3.6A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A)","0.41A","4fh2A-5ll7A:35.2","4euzA-5ll7A:22.54"],["4N9K_A_CEDA301_1","BETA-LACTAMASE","5ll7","BETA-LACTAMASE","Escherichia coli",7,"SER A  70;SER A 130;ASN A 132;ASN A 170;LYS A 234;THR A 235;GLY A 236","6YV A 301 (-1.7A);6YV A 301 (-2.6A);6YV A 301 (-3.7A);6YV A 301 (-2.9A);6YV A 301 (-3.6A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A)","0.50A","4n9kA-5ll7A:42.0","4fh2A-5ll7A:16.80"],["4N9K_B_CEDB301_1","BETA-LACTAMASE","5ll7","BETA-LACTAMASE","Escherichia coli",7,"SER A  70;SER A 130;ASN A 132;ASN A 170;LYS A 234;THR A 235;GLY A 236","6YV A 301 (-1.7A);6YV A 301 (-2.6A);6YV A 301 (-3.7A);6YV A 301 (-2.9A);6YV A 301 (-3.6A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A)","0.48A","4n9kB-5ll7A:42.0","4n9kA-5ll7A:17.57"],["4PB1_A_RBVA501_1","NUPC FAMILY PROTEIN","5ll7","BETA-LACTAMASE","Escherichia coli",5,"GLY A  74;ALA A  77;LEU A 148;ASN A 136;ASN A 132","None;None;None;None;6YV A 301 (-3.7A)","1.37A","4pb1A-5ll7A:undetectable","4n9kB-5ll7A:17.57"],["4PM5_A_CE3A301_1","BETA-LACTAMASE CTX-M-14","5ll7","BETA-LACTAMASE","Escherichia coli",7,"SER A 130;ASN A 132;ASN A 170;THR A 216;LYS A 234;THR A 235;GLY A 236","6YV A 301 (-2.6A);6YV A 301 (-3.7A);6YV A 301 (-2.9A);6YV A 301 ( 4.2A);6YV A 301 (-3.6A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A)","0.65A","4pm5A-5ll7A:43.1","4pb1A-5ll7A:13.41"],["4PM5_A_CE3A301_1","BETA-LACTAMASE CTX-M-14","5ll7","BETA-LACTAMASE","Escherichia coli",6,"SER A 130;THR A 216;LYS A 234;THR A 235;GLY A 236;GLY A 239","6YV A 301 (-2.6A);6YV A 301 ( 4.2A);6YV A 301 (-3.6A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A);None","0.88A","4pm5A-5ll7A:43.1","4pm5A-5ll7A:16.60"],["4PM7_A_CE3A301_1","BETA-LACTAMASE CTX-M-14","5ll7","BETA-LACTAMASE","Escherichia coli",7,"LYS A  73;SER A 130;ASN A 132;ASN A 170;THR A 216;LYS A 234;GLY A 236","6YV A 301 ( 3.8A);6YV A 301 (-2.6A);6YV A 301 (-3.7A);6YV A 301 (-2.9A);6YV A 301 ( 4.2A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A)","0.71A","4pm7A-5ll7A:43.0","4pm5A-5ll7A:16.60"],["4PM9_A_CE3A301_1","BETA-LACTAMASE CTX-M-14","5ll7","BETA-LACTAMASE","Escherichia coli",7,"SER A 130;ASN A 132;ASN A 170;THR A 216;LYS A 234;THR A 235;GLY A 236","6YV A 301 (-2.6A);6YV A 301 (-3.7A);6YV A 301 (-2.9A);6YV A 301 ( 4.2A);6YV A 301 (-3.6A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A)","0.63A","4pm9A-5ll7A:42.6","4pm7A-5ll7A:16.60"],["4ZXI_A_GLYA1402_0","TYROCIDINE SYNTHETASE 3","5ll7","BETA-LACTAMASE","Escherichia coli",4,"ASP A 246;ILE A 221;GLY A 232;THR A 235","None;None;None;6YV A 301 (-3.6A)","1.16A","4zxiA-5ll7A:undetectable","4pm9A-5ll7A:16.60"],["5GHY_A_CEDA301_1","BETA-LACTAMASE","5ll7","BETA-LACTAMASE","Escherichia coli",6,"SER A  70;SER A 130;ASN A 132;ASN A 170;LYS A 234;GLY A 236","6YV A 301 (-1.7A);6YV A 301 (-2.6A);6YV A 301 (-3.7A);6YV A 301 (-2.9A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A)","0.55A","5ghyA-5ll7A:42.2","4zxiA-5ll7A:undetectable"],["5GHY_B_CEDB301_1","BETA-LACTAMASE","5ll7","BETA-LACTAMASE","Escherichia coli",6,"SER A  70;SER A 130;ASN A 132;ASN A 170;LYS A 234;GLY A 236","6YV A 301 (-1.7A);6YV A 301 (-2.6A);6YV A 301 (-3.7A);6YV A 301 (-2.9A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A)","0.52A","5ghyB-5ll7A:42.2","5ghyA-5ll7A:17.57"],["5GHZ_A_CEDA301_1","BETA-LACTAMASE","5ll7","BETA-LACTAMASE","Escherichia coli",7,"SER A  70;SER A 130;ASN A 132;ASN A 170;LYS A 234;THR A 235;GLY A 236","6YV A 301 (-1.7A);6YV A 301 (-2.6A);6YV A 301 (-3.7A);6YV A 301 (-2.9A);6YV A 301 (-3.6A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A)","0.50A","5ghzA-5ll7A:42.1","5ghyB-5ll7A:17.57"],["5GHZ_B_CEDB301_1","BETA-LACTAMASE","5ll7","BETA-LACTAMASE","Escherichia coli",7,"SER A  70;SER A 130;ASN A 132;ASN A 170;LYS A 234;THR A 235;GLY A 236","6YV A 301 (-1.7A);6YV A 301 (-2.6A);6YV A 301 (-3.7A);6YV A 301 (-2.9A);6YV A 301 (-3.6A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A)","0.50A","5ghzB-5ll7A:42.1","5ghzA-5ll7A:17.57"],["5OJ0_A_9WTA801_0","PENICILLIN-BINDING PROTEIN 2X","5ll7","BETA-LACTAMASE","Escherichia coli",5,"SER A 130;ASN A 132;THR A 216;GLY A 236;THR A 237","6YV A 301 (-2.6A);6YV A 301 (-3.7A);6YV A 301 ( 4.2A);6YV A 301 ( 4.0A);6YV A 301 (-3.6A)","1.23A","5oj0A-5ll7A:7.3","5ghzB-5ll7A:17.57"],["5YVN_A_ACTA305_0","GLUTATHIONE S-TRANSFERASE OMEGA-1","5ll7","BETA-LACTAMASE","Escherichia coli",4,"LEU A 169;LYS A  73;LEU A  76;LEU A 139","None;6YV A 301 ( 3.8A);None;None","0.98A","5yvnA-5ll7A:undetectable","5oj0A-5ll7A:undetectable"],["6B5Y_B_9F2B400_1","BETA-LACTAMASE","5ll7","BETA-LACTAMASE","Escherichia coli",9,"SER A  70;SER A 130;ASN A 170;THR A 216;ARG A 220;LYS A 234;THR A 235;GLY A 236;THR A 237","6YV A 301 (-1.7A);6YV A 301 (-2.6A);6YV A 301 (-2.9A);6YV A 301 ( 4.2A);6YV A 301 ( 3.7A);6YV A 301 (-3.6A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A);6YV A 301 (-3.6A)","0.43A","6b5yB-5ll7A:40.2","5yvnA-5ll7A:undetectable"],["6B5Y_B_9F2B400_1","BETA-LACTAMASE","5ll7","BETA-LACTAMASE","Escherichia coli",6,"THR A 216;ARG A 220;LYS A 234;THR A 235;THR A 237;GLY A 239","6YV A 301 ( 4.2A);6YV A 301 ( 3.7A);6YV A 301 (-3.6A);6YV A 301 (-3.6A);6YV A 301 (-3.6A);None","0.82A","6b5yB-5ll7A:40.2","6b5yB-5ll7A:40.00"],["6B5Y_D_9F2D400_1","BETA-LACTAMASE","5ll7","BETA-LACTAMASE","Escherichia coli",9,"SER A  70;SER A 130;ASN A 170;THR A 216;LYS A 234;THR A 235;GLY A 236;THR A 237;GLU A 276","6YV A 301 (-1.7A);6YV A 301 (-2.6A);6YV A 301 (-2.9A);6YV A 301 ( 4.2A);6YV A 301 (-3.6A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A);6YV A 301 (-3.6A);None","0.47A","6b5yD-5ll7A:40.3","6b5yB-5ll7A:40.00"],["6B68_B_9F2B301_1","BETA-LACTAMASE","5ll7","BETA-LACTAMASE","Escherichia coli",8,"SER A  70;SER A 130;ASN A 170;THR A 216;LYS A 234;THR A 235;GLY A 236;THR A 237","6YV A 301 (-1.7A);6YV A 301 (-2.6A);6YV A 301 (-2.9A);6YV A 301 ( 4.2A);6YV A 301 (-3.6A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A);6YV A 301 (-3.6A)","0.36A","6b68B-5ll7A:40.3","6b5yD-5ll7A:40.00"],["6B68_D_9F2D400_1","BETA-LACTAMASE","5ll7","BETA-LACTAMASE","Escherichia coli",9,"SER A  70;SER A 130;ASN A 170;THR A 216;ARG A 220;LYS A 234;GLY A 236;THR A 237;GLU A 276","6YV A 301 (-1.7A);6YV A 301 (-2.6A);6YV A 301 (-2.9A);6YV A 301 ( 4.2A);6YV A 301 ( 3.7A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A);6YV A 301 (-3.6A);None","0.38A","6b68D-5ll7A:40.2","6b68B-5ll7A:40.00"],["6B69_B_9F2B301_1","BETA-LACTAMASE;BETA-LACTAMASE","5ll7","BETA-LACTAMASE","Escherichia coli",8,"SER A  70;SER A 130;ASN A 170;THR A 216;LYS A 234;THR A 235;GLY A 236;THR A 237","6YV A 301 (-1.7A);6YV A 301 (-2.6A);6YV A 301 (-2.9A);6YV A 301 ( 4.2A);6YV A 301 (-3.6A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A);6YV A 301 (-3.6A)","0.40A","6b69A-5ll7A:40.2;6b69B-5ll7A:40.2","6b68D-5ll7A:40.00"],["6B69_D_9F2D301_1","BETA-LACTAMASE","5ll7","BETA-LACTAMASE","Escherichia coli",10,"SER A  70;SER A 130;ASN A 170;THR A 216;ARG A 220;LYS A 234;THR A 235;GLY A 236;THR A 237;GLU A 276","6YV A 301 (-1.7A);6YV A 301 (-2.6A);6YV A 301 (-2.9A);6YV A 301 ( 4.2A);6YV A 301 ( 3.7A);6YV A 301 (-3.6A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A);6YV A 301 (-3.6A);None","0.38A","6b69D-5ll7A:40.1","6b69A-5ll7A:40.00;6b69B-5ll7A:40.00"],["6B69_D_9F2D301_1","BETA-LACTAMASE","5ll7","BETA-LACTAMASE","Escherichia coli",6,"THR A 216;ARG A 220;THR A 235;THR A 237;GLY A 239;GLU A 276","6YV A 301 ( 4.2A);6YV A 301 ( 3.7A);6YV A 301 (-3.6A);6YV A 301 (-3.6A);None;None","0.78A","6b69D-5ll7A:40.1","6b69D-5ll7A:40.00"],["6B6A_B_9F2B301_1","BETA-LACTAMASE","5ll7","BETA-LACTAMASE","Escherichia coli",9,"SER A  70;SER A 130;ASN A 170;THR A 216;ARG A 220;LYS A 234;THR A 235;GLY A 236;THR A 237","6YV A 301 (-1.7A);6YV A 301 (-2.6A);6YV A 301 (-2.9A);6YV A 301 ( 4.2A);6YV A 301 ( 3.7A);6YV A 301 (-3.6A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A);6YV A 301 (-3.6A)","0.36A","6b6aB-5ll7A:40.3","6b69D-5ll7A:40.00"],["6B6A_D_9F2D301_1","BETA-LACTAMASE","5ll7","BETA-LACTAMASE","Escherichia coli",9,"SER A  70;SER A 130;ASN A 170;ARG A 220;LYS A 234;THR A 235;GLY A 236;THR A 237;GLU A 276","6YV A 301 (-1.7A);6YV A 301 (-2.6A);6YV A 301 (-2.9A);6YV A 301 ( 3.7A);6YV A 301 (-3.6A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A);6YV A 301 (-3.6A);None","0.38A","6b6aD-5ll7A:40.3","6b6aB-5ll7A:40.00"],["6B6C_A_9F2A301_1","BETA-LACTAMASE","5ll7","BETA-LACTAMASE","Escherichia coli",8,"SER A  70;SER A 130;ASN A 170;ARG A 220;LYS A 234;THR A 235;GLY A 236;THR A 237","6YV A 301 (-1.7A);6YV A 301 (-2.6A);6YV A 301 (-2.9A);6YV A 301 ( 3.7A);6YV A 301 (-3.6A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A);6YV A 301 (-3.6A)","0.47A","6b6cA-5ll7A:40.0","6b6aD-5ll7A:40.00"],["6B6C_A_9F2A301_1","BETA-LACTAMASE","5ll7","BETA-LACTAMASE","Escherichia coli",6,"SER A 130;PRO A 104;ARG A 220;LYS A 234;THR A 235;THR A 237","6YV A 301 (-2.6A);None;6YV A 301 ( 3.7A);6YV A 301 (-3.6A);6YV A 301 (-3.6A);6YV A 301 (-3.6A)","1.34A","6b6cA-5ll7A:40.0","6b6cA-5ll7A:40.00"],["6B6D_A_9F2A302_1","BETA-LACTAMASE","5ll7","BETA-LACTAMASE","Escherichia coli",8,"SER A  70;SER A 130;ASN A 170;THR A 216;LYS A 234;THR A 235;GLY A 236;THR A 237","6YV A 301 (-1.7A);6YV A 301 (-2.6A);6YV A 301 (-2.9A);6YV A 301 ( 4.2A);6YV A 301 (-3.6A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A);6YV A 301 (-3.6A)","0.40A","6b6dA-5ll7A:40.0","6b6cA-5ll7A:40.00"],["6B6D_A_9F2A302_1","BETA-LACTAMASE","5ll7","BETA-LACTAMASE","Escherichia coli",6,"SER A 130;THR A 216;LYS A 234;THR A 235;THR A 237;GLY A 239","6YV A 301 (-2.6A);6YV A 301 ( 4.2A);6YV A 301 (-3.6A);6YV A 301 (-3.6A);6YV A 301 (-3.6A);None","0.87A","6b6dA-5ll7A:40.0","6b6dA-5ll7A:40.00"],["6B6E_A_9F2A302_1","BETA-LACTAMASE","5ll7","BETA-LACTAMASE","Escherichia coli",9,"SER A  70;SER A 130;ASN A 170;THR A 216;ARG A 220;LYS A 234;THR A 235;GLY A 236;THR A 237","6YV A 301 (-1.7A);6YV A 301 (-2.6A);6YV A 301 (-2.9A);6YV A 301 ( 4.2A);6YV A 301 ( 3.7A);6YV A 301 (-3.6A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A);6YV A 301 (-3.6A)","0.37A","6b6eA-5ll7A:40.1","6b6dA-5ll7A:40.00"],["6B6F_A_9F2A301_1","BETA-LACTAMASE","5ll7","BETA-LACTAMASE","Escherichia coli",8,"CSS A  69;SER A  70;SER A 130;ASN A 170;LYS A 234;THR A 235;GLY A 236;THR A 237","None;6YV A 301 (-1.7A);6YV A 301 (-2.6A);6YV A 301 (-2.9A);6YV A 301 (-3.6A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A);6YV A 301 (-3.6A)","0.61A","6b6fA-5ll7A:39.6","6b6eA-5ll7A:40.00"],["6C79_A_CE3A301_1","BETA-LACTAMASE TOHO-1","5ll7","BETA-LACTAMASE","Escherichia coli",6,"SER A 130;ASN A 132;ASN A 170;THR A 216;LYS A 234;GLY A 236","6YV A 301 (-2.6A);6YV A 301 (-3.7A);6YV A 301 (-2.9A);6YV A 301 ( 4.2A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A)","0.66A","6c79A-5ll7A:43.3","6b6fA-5ll7A:40.00"],["6C79_A_CE3A301_1","BETA-LACTAMASE TOHO-1","5ll7","BETA-LACTAMASE","Escherichia coli",5,"SER A 130;THR A 216;LYS A 234;GLY A 236;GLY A 239","6YV A 301 (-2.6A);6YV A 301 ( 4.2A);6YV A 301 (-3.6A);6YV A 301 ( 4.0A);None","0.92A","6c79A-5ll7A:43.3","6c79A-5ll7A:33.75"]]